Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Penile metastasis from prostate cancer with CDK12 mutation: A case report and literature review. | Oncol Lett | 2026 | 41743014 | PubTator, text mining | PubMed |
| BRCA2 and NF2-Mutated High-Grade Renal Cell Carcinoma: A Case Report and Literature Review. | Int J Surg Pathol | 2026 | 41731704 | PubTator, text mining | PubMed |
| Development and validation of a combined diagnostic model for prostate cancer integrating MRI parameters with p504s, CK5/6, and Ki-67 expression. | Open Life Sci | 2026 | 41726553 | PubTator, text mining | PubMed |
| Renal-Type Clear Cell Carcinoma of the Prostate: A Histopathological Case Report of a Rare and Underrecognized Variant. | Reports (MDPI) | 2026 | 41718313 | PubTator, text mining | PubMed |
| Comparison of digital displays for efficient diagnosis and accuracy. | J Pathol Inform | 2026 | 41716691 | PubTator, text mining | PubMed |
| ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases. | Mod Pathol | 2026 | 41690476 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing analysis reveals peroxisome-related biomarkers in osteoarthritis lipid metabolism. | Int J Biol Macromol | 2026 | 41638276 | PubTator, text mining | PubMed |
| Multiple Distinct Renal Cell Carcinomas in a Patient With Acquired Cystic Kidney Disease: A Case Report and Literature Review. | Int J Surg Pathol | 2026 | 41442260 | PubTator, text mining | PubMed |
| Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high-frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis. | Histopathology | 2026 | 41263779 | PubTator, text mining | PubMed |
| Chromosomal alterations in 7, 17, and Y demonstrate comparable sensitivity and superior specificity to diffuse strong AMACR immunostaining for papillary renal cell carcinoma. | Ann Diagn Pathol | 2026 | 41151238 | PubTator, text mining | PubMed |
| Biphasic (squamoid) papillary renal cell carcinoma: a distinct molecular and morphologic subtype within the PRCC spectrum. | Virchows Arch | 2026 | 41006900 | PubTator, text mining | PubMed |
| CD63 is a diagnostic marker of prostate cancer and a prognostic marker of biochemical progression following radical prostatectomy. | Histol Histopathol | 2026 | 40916710 | PubTator, text mining | PubMed |
| Fistula-Associated Perianal Mucinous Adenocarcinoma. | Int J Surg Pathol | 2026 | 40625121 | PubTator, text mining | PubMed |
| Pathogenesis-Guided Biomarker Assessment: A Shift in Prostate Cancer Diagnostics. | Int J Mol Sci | 2025 | 41465218 | PubTator, text mining | PubMed |
| A case report: identifying a novel variant in ELOC(TCEB1)-mutant renal cell carcinoma. | Front Oncol | 2025 | 41306531 | PubTator, text mining | PubMed |
| Annotation-Free Prediction of Cancer Cells and Glands and Spatial Analysis of Immune Cells. | bioRxiv | 2025 | 41292954 | PubTator, text mining | PubMed |
| Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report. | Front Immunol | 2025 | 41280897 | PubTator, text mining | PubMed |
| Rare Case of Collecting Duct Carcinoma With Complete Response to Nivolumab. | Case Rep Oncol Med | 2025 | 41195202 | PubTator, text mining | PubMed |
| THRESHOLD: a comprehensive transcriptomic analysis tool for evaluating gene saturation and impact in disease progression. | NAR Cancer | 2025 | 41180010 | PubTator, text mining | PubMed |
| Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: A Rare Renal Neoplasm-Case Report and Literature Review. | Reports (MDPI) | 2025 | 41133530 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=3